Related Experiment Video
Updated: Jun 13, 2026
09:54
Laboratory Scale Production and Purification of a Therapeutic Antibody
Published on: January 24, 2017
Therapeutic antibodies: past, present and future
Nature Reviews. Immunology
|April 29, 2010
Summary
The monoclonal antibody market has seen rapid growth. This issue covers antibody biology and therapeutic applications, highlighting advancements and hurdles in developing safe, effective, and accessible antibody therapies.
Area of Science:
- Immunology
- Biotechnology
- Pharmacology
Background:
- The market for monoclonal antibodies has experienced exponential growth over the last decade.
- This special issue compiles research on the fundamental biology of antibodies.
- It also covers the evolving landscape of their therapeutic applications.
Discussion:
- Explores the latest scientific prospects in antibody development.
- Addresses the ongoing challenges in creating therapeutic antibodies.
- Focuses on achieving safety, efficiency, and affordability.
Key Insights:
- Provides a comprehensive overview of current antibody research.
- Highlights the dual focus on basic antibody science and clinical utility.
- Emphasizes the critical need for accessible antibody-based treatments.
Outlook:
- Discusses future directions and potential breakthroughs in antibody engineering.
- Identifies key areas for innovation to overcome development challenges.
- Projects the continued expansion and impact of therapeutic antibodies.
More Related Videos
Related Concept Videos
01:31Hybridoma Technology
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
00:42Cross-reactivity
Overview
01:26Antibody Actions
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
01:16Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...